Nordea Investment Management Ab Arcus Biosciences, Inc. Transaction History
Nordea Investment Management Ab
- $92.5 Billion
- Q1 2025
A detailed history of Nordea Investment Management Ab transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Nordea Investment Management Ab holds 273,123 shares of RCUS stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
273,123
Previous 218,930
24.75%
Holding current value
$2.49 Million
Previous $3.26 Million
34.21%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RCUS
# of Institutions
200Shares Held
63.1MCall Options Held
116KPut Options Held
116K-
Black Rock Inc. New York, NY9.76MShares$89.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.69MShares$61.1 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA5.13MShares$46.8 Million0.28% of portfolio
-
State Street Corp Boston, MA3.7MShares$33.7 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.87MShares$26.2 Million0.06% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $659M
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...